FindTrial
Sign In

Use of two different drungs as adjuvant to levobupivacaine for spinal anaesthesia in lower limb surgeries.

Comparison of Nalbuphine and MgSO4 as an adjuvant to 0.5% Hyperbaric Levobupivacaine in subarachnoid blockade for lower limb surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017756
Enrollment
135
Registered
2019-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S90-S99- Injuries to the ankle and foot Health Condition 2: S70-S79- Injuries to the hip and thigh Health Condition 3: S80-S89- Injuries to the knee and lower leg

Interventions

Intervention1: Nalbuphine: 0.8 mg Nalbuphine wiil be administered with 15 mg (0.5%) hyperbaric levobupivacaine for subarachnoid blaockade in patients undergoing lower limb surgeries. Intervention2: Ma

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1, 2 Patients scheduled to have various lower limb sugeries.

Exclusion criteria

Exclusion criteria: Patient who refuse to participate in study. Patients not opting for subarachnoid block as anaesthetic technique. Patients with local infection or significant coagulopathy. Patients with severe cardiopulmonary disease. Patients with blood volume deficit. Patients with allergy to local anaesthetics or study drugs. Patients with long term opioid use. Patients with Peripheral Neuropathies,scoliosis.

Design outcomes

Primary

MeasureTime frame
Level of Sensory blockadeTimepoint: Minutes 1,3,5,10,15,20,30 and 60.—

Secondary

MeasureTime frame
Full recovery of Sensory blockadeTimepoint: Hours 6 and 12.—

Countries

India

Contacts

Public ContactDr Kavita Meena

Institute of Medical Sciences

kvtamn68@gmail.com9455231073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026